Part of the industry defining Microbiome Movement, the 2nd Microbiome Movement – Gut-Brain Axis 2018 returns this November to help large pharma, biotech, and forward-thinking research institutes deepen their mechanistic understanding of microbiota-host interactions across a range of complex CNS diseases including Parkinson’s, MS, ASD, PTSD, Stress & Depression.

Through data driven case studies showcasing the latest pre-clinical and clinical research, uncover the role of multiple metabolic and immune-mediated pathways that are being proven to show an effect in the cause and development of CNS disease. This is your chance to get to grips with the latest animal and clinical data proving the communication between gut and brain is real and ultimately capitalize on this exciting therapeutic opportunity.

Take a look at the event guide now to see the finalized program and meet the speakers.